Antibody Analytics Limited

ActiveSC520998 Private limited company
Incorporated
24 November 2015 (10 years)
Industry
Other professional, scientific and technical activities n.e.c. (74909)
Directors
Owned by
Accounts type
Full
Region
Scotland
Address
Rouken Discovery Centre
Braidhurst Industrial Estate
Motherwell
ML1 3ST

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
10 December 2026
Last conf. stmt
26 November 2025

Charges

Total
4
Outstanding
3
Part satisfied
1
Satisfied
0

Officers 3 active

Officer details are public data from the Companies House register.

Director · Appointed 3 May 2024
Also at Project Steel Acquireco Limited, Rouken Bio Limited · more companies
British
Born February 1980 (46)
Director · Appointed 11 January 2016
Also at Rouken Bio Limited
British
Born September 1979 (47)
Director · Appointed 24 November 2015
Also at Rouken Bio Limited
British
Born July 1978 (48)
Officer history (4 former)
3 May 2024
Appointed Mcdonald, Alan Thomas as Director
8 May 2019
Resigned Baron, Andrew Wiliam, Dr as Director
11 January 2016
Appointed Upsall, Andrew Richard as Director
11 January 2016
Appointed Baron, Andrew Wiliam, Dr as Director
24 November 2015
Appointed Downie, Michahaila Julia as Director
24 November 2015
Appointed Cosec Limited as Corporate Secretary
24 November 2015
Resigned Cosec Limited as Corporate Secretary
24 November 2015
Appointed Mcmeekin, James Stuart as Director
24 November 2015
Resigned Mcmeekin, James Stuart as Director
24 November 2015
Appointed Cosec Limited as Corporate Director
24 November 2015
Resigned Cosec Limited as Corporate Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 12 October 2023
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. Sc780681

Holdings 1

Companies where Antibody Analytics Limited is registered as a person with significant control

Owns 75–100% of shares
Active
Former controllers (2)
12 October 2023
Ceased Michahaila Julia Downie — Owns 25–50% of shares
12 October 2023
Ceased Andrew Richard Upsall — Owns 25–50% of shares

Group structure 53 shown

Ownership group derived from the Companies House PSC register

Northedge Capital LLP
Bliss Newco Limited Owns 75–100% of shares
Bliss Topco Limited Owns 75–100% of shares
Cyclone 33 Topco Limited Holds 75–100% of voting rights (as a firm)
Cyclone 33 Midco Limited Owns 75–100% of shares
Cyclone 33 Bidco Limited Owns 75–100% of shares
Friend MTS Limited Owns 50–75% of shares
Northedge Capital Corporate Limited Owns 75–100% of shares
Northedge Capital Founder GP Limited Owns 75–100% of shares
Northedge Capital II Founder GP LLP Holds 25–50% of voting rights
Northedge Capital Iii Founder GP LLP Holds 25–50% of voting rights
Northedge Capital Iii GP LLP Holds 25–50% of voting rights
Northedge Capital IV Founder GP LLP Holds 25–50% of voting rights
Northedge Capital IV GP LLP Holds 25–50% of voting rights
Northedge Capital Sme Founder I GP LLP Holds 25–50% of voting rights
Northedge Capital Sme GP I LLP Holds 25–50% of voting rights
Northedge Capital Fund I GP Limited Owns 75–100% of shares
Northedge Capital I GP LLP Has significant influence or control
Northedge Capital II GP LLP Has significant influence or control (as a trust)
Northedge Capital Founder II LP Has significant influence or control
Northedge Capital Founder Iii LP Has significant influence or control
Northedge Capital Founder, L.P. Has significant influence or control
Northedge Capital Nominee Limited Owns 75–100% of shares
Apollo Topco Limited Owns 50–75% of shares
Apollo Bidco Limited Owns 75–100% of shares
Hamsard 3466 Limited Owns 50–75% of shares
Hamsard 3465 Limited Owns 75–100% of shares
Hamsard 3766 Limited Owns 75–100% of shares
Hamsard 3769 Limited Owns 75–100% of shares
League Topco Limited Owns 50–75% of shares
League Midco Limited Owns 75–100% of shares
Northedge Capital Founder IV LP Part right to 75–100% of surplus assets
Project Alpine Topco Limited Owns 25–50% of shares
Project Alpine Bidco Limited Owns 75–100% of shares
Project Georgia Topco Limited Status not confirmedHolds 50–75% of voting rights
Project Georgia Bidco Limited Status not confirmedOwns 75–100% of shares
Project Steel Acquireco Limited Holds 25–50% of voting rights
Antibody Analytics Limited This company Owns 75–100% of shares
Project Sword Topco Limited In liquidationOwns 25–50% of shares
Project Sword Midco 1 Limited In liquidationOwns 75–100% of shares
Project Canopy Topco Limited Owns 75–100% of shares
Project Canopy Midco Limited Owns 75–100% of shares
Project Canopy Bidco Limited Owns 75–100% of shares
Project Dartmoor Topco Limited Has significant influence or control
Project Dartmoor Midco Limited Owns 75–100% of shares
Project Dartmoor Bidco Limited Owns 75–100% of shares
Project Panda Topco Limited Has significant influence or control
Project Panda Bidco Limited Owns 75–100% of shares
Meet Life Sciences Group Limited Owns 75–100% of shares
Project Star Topco Limited Has significant influence or control
Project Star Bidco Limited Owns 75–100% of shares
Cadran Services Limited Owns 75–100% of shares
Tereo Limited Owns 50–75% of shares

Financials

Balance sheet as at 31 December 2025 · full accounts

Net Assets
£3,930,254
Cash
£2,503,374
Profit Before Tax
£577,371
Debt Ratio
70%
Current Ratio
2.2x
Return on Equity
38%

Trend

Net Assets
£0 £2.0M £4.0M 2019 2020 2021 2022 2023 2024 2025 £609,638 £298,893 £846,155 £767,505 £1,194,646 £2,433,190 £3,930,254
Balance sheet detail
2025202420232022202120202019
Fixed Assets£7,153,131£6,362,921£2,197,903£1,889,999£1,408,182£807,895£695,067
Current Assets£5,768,263£5,412,074£7,240,363£1,595,090£1,520,643£1,401,208£1,513,206
Debtors£2,439,939£1,577,287£846,466£585,904£576,919£437,025£557,871
Cash£2,503,374£3,005,637£6,272,425£913,276£842,559£964,183£955,335
Creditors (< 1 year)£2,607,615£9,043,869
Creditors (> 1 year)£6,383,525£297,936£7,416,669£1,709,197£1,124,451£1,065,864£627,653
Net Current Assets£3,160,648(£3,631,795)£6,413,412£586,703£562,424£556,862£542,224
Net Assets£3,930,254£2,433,190£1,194,646£767,505£846,155£298,893£609,638
Shareholder Funds£3,930,254£2,433,190

What Antibody Analytics say about themselves

“Partner with RoukenBio, a pre-clinical immunology contract research organisation, to propel your drug discovery breakthroughs. Talk to our experts today.”

— from antibodyanalytics.com

Filings 76

DateDescriptionMade Up ToPagesPDF
21 May 2026Full accounts31 December 2025
3 December 2025Confirmation statement with updates26 November 2025
8 September 2025Full accounts31 December 2024
4 December 2024Confirmation statement with updates26 November 2024
26 September 2024Director's details changed
Show all 76 filings

Some other companies at this address

Project Steel Acquireco Limited
Rouken Bio Limited

Other companies in this industry

London
Watford
St Davids Park Ewloe
Milton Keynes
London
Horncastle

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?